Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02477826 |
|---|---|
| Brief Title: | An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) (CheckMate 227) |
| First Submitted : | June 18, 2015 |
| First Submitted that Met QC Criteria : | June 18, 2015 |
| First Posted : | June 23, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 5, 2024 |
| Last Update Posted : | January 8, 2024 |